Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Msle Stock Analysis Satellos Bioscience Inc. 2.81 Pct Dip To 5.87 Key Insights 20260403 1 The opportunity most miss about Nuwellis NUWE Technical Weakness 20260511 Xunlei XNET Stock Performance Drivers Analysis MENS Jyong Biotech drops 369 on weak Q1 2025 earnings marked by zero revenue and negative EPS JBT Marel JBTM Stock 52Week Low Calm 20260420 JDcom Inc JD PostRally Underperformance Upcoming Earnings Catalyst and Valuation Outlook Edison International EIX Q1 Earnings Beat Reaffirmed Guidance Support Bullish Outlook Despite Minor Barclays Price Target Adjustment The competitive moat visible in Powell Max PMAX earnings PMAX Latest Quarter Earnings Powell Max delays earnings release amid internal review QRVO Qorvo posts 151 percent Q1 2026 EPS beat shares jump 895 percent amid positive investor sentiment ENVX Enovix Corporation reports narrower Q4 2025 loss than analyst estimates shares rise modestly on positive investor sentiment Hydrofarm HYFM Q3 2025 Earnings Miss Sparks Concern Baosheng BAOS Declines 662 Amid Market Weakness 20260515 Newbury NTWO Unchanged at 1062 RangeBound Trading 20260518 Is electroCore ECOR Still a Buy After 154 Rally 20260519 Taiwan Stocks Surge as Weighted Index Gains 218 on Broad Market Rally Kashkari Warns Middle East Energy Risks May Prolong Feds Cautious Stance AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests Infrastructure Control Emerges as Potential Key to Financial Edge Indian Stock Market Faces Profit Booking After ThreeDay Rally Vietnams Counterfeiting and Piracy Issues Persist Ahead of US Tariff Deadline OCFC Q1 2026 Earnings EPS Beat of 591 Highlights Resilience Amid Slight Stock Decline Teleflex TFX Q1 2026 Earnings EPS Beats Estimates by 14 as Stock Dips on Cautious Sentiment BKD Q1 2026 Earnings EPS Misses Estimates as Senior Living Operator Navigates Cost Headwinds MRNA Q1 2026 Earnings NarrowerThanExpected Loss Despite Revenue Absence Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges